INS and type 2 diabetes mellitus: Compared with healthy individuals, incretin-induced insulin secretory responses in type 2 diabetes seem to be reduced more (Fig. 3), with less well-controlled plasma glucose concentrations (indicated by lower baseline HbA1c levels, fewer diabetes medications; ESM Table 2).